T36.6X6

Clinical Causes: Inadequate prescription or dosing errors made by healthcare providers Poor patient adherence to prescribed medication regimens Limited access to medications due to financial or logistical barriers Prescribing lower doses intentionally to avoid side effects, without proper medical guidance Alterations in metabolism or absorption of the drug in individual patients Drug interactions that diminish the effectiveness or absorption of rifampicin

Key Symptoms: Persistent or worsening symptoms of the underlying infection, such as cough in tuberculosis Signs of ongoing bacterial activity, including fever and fatigue Lack of expected improvement despite treatment Possible development of drug resistance if underdosing continues over time No specific symptoms directly attributable to underdosing; rather, ongoing infection signifies inadequate therapy

Diagnosis Path: Microbiological tests, including sputum analysis in tuberculosis cases, to check for ongoing bacterial presence Drug level measurements in the blood to confirm subtherapeutic concentrations Reviewing prescription records and medication adherence through patient interviews or pharmacy data Assessment of clinical symptoms and radiological imaging to evaluate disease progression or resolution

Treatment Protocols: Re-evaluating and adjusting the dosage based on patient-specific factors and clinical guidelines Providing patient education to enhance understanding and adherence to prescribed regimens Monitoring blood levels to confirm therapeutic drug concentrations Managing and mitigating any side effects that may contribute to non-compliance Addressing any barriers to medication access, such as financial or logistical challenges Close follow-up with healthcare providers during therapy to detect and address issues promptly